JP2023512827A5 - - Google Patents
Info
- Publication number
- JP2023512827A5 JP2023512827A5 JP2022548123A JP2022548123A JP2023512827A5 JP 2023512827 A5 JP2023512827 A5 JP 2023512827A5 JP 2022548123 A JP2022548123 A JP 2022548123A JP 2022548123 A JP2022548123 A JP 2022548123A JP 2023512827 A5 JP2023512827 A5 JP 2023512827A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- molecule according
- binding molecule
- cancer
- alppl2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025172731A JP2026027248A (ja) | 2020-02-07 | 2025-10-14 | 抗原結合分子およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202001139U | 2020-02-07 | ||
| SG10202001139U | 2020-02-07 | ||
| PCT/SG2021/050061 WO2021158178A1 (en) | 2020-02-07 | 2021-02-05 | Antigen-binding molecules against alppl2 and/or alpp and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025172731A Division JP2026027248A (ja) | 2020-02-07 | 2025-10-14 | 抗原結合分子およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512827A JP2023512827A (ja) | 2023-03-29 |
| JP2023512827A5 true JP2023512827A5 (https=) | 2024-02-14 |
Family
ID=77199411
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548123A Pending JP2023512827A (ja) | 2020-02-07 | 2021-02-05 | 抗原結合分子およびその使用 |
| JP2025172731A Pending JP2026027248A (ja) | 2020-02-07 | 2025-10-14 | 抗原結合分子およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025172731A Pending JP2026027248A (ja) | 2020-02-07 | 2025-10-14 | 抗原結合分子およびその使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20230080224A1 (https=) |
| EP (1) | EP4100443A4 (https=) |
| JP (2) | JP2023512827A (https=) |
| KR (1) | KR20220139930A (https=) |
| CN (1) | CN115380050A (https=) |
| AU (1) | AU2021217919A1 (https=) |
| BR (1) | BR112022015540A2 (https=) |
| CA (1) | CA3170141A1 (https=) |
| CL (3) | CL2022002114A1 (https=) |
| CO (1) | CO2022011944A2 (https=) |
| CR (1) | CR20220441A (https=) |
| DO (2) | DOP2022000159A (https=) |
| EC (1) | ECSP22061867A (https=) |
| IL (1) | IL295291A (https=) |
| JO (1) | JOP20220175A1 (https=) |
| MX (1) | MX2022009709A (https=) |
| PE (1) | PE20221781A1 (https=) |
| PH (1) | PH12022552038A1 (https=) |
| WO (1) | WO2021158178A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120882866A (zh) * | 2022-12-21 | 2025-10-31 | 阿尔麦克探索有限公司 | Alpp特异性变体抗原结合分子 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| BRPI0914251B1 (pt) * | 2008-06-25 | 2022-07-19 | Novartis Ag | Imunoligante recombinante, seu fragmento de ligação ao antígeno, uso dos mesmos, e composição |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| SI3383920T1 (sl) * | 2015-11-30 | 2024-06-28 | The Regents Of The University Of California | Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic |
| JP2019131471A (ja) * | 2016-05-27 | 2019-08-08 | 国立大学法人 東京大学 | 抗ＴＧＦ−ｂｅｔａ３抗体およびその使用 |
| CN108088997B (zh) * | 2016-11-21 | 2020-03-17 | 同济大学 | 利用细胞表面分子标志物鉴定人类原态多能性的方法 |
-
2021
- 2021-02-05 US US17/798,025 patent/US20230080224A1/en active Pending
- 2021-02-05 JP JP2022548123A patent/JP2023512827A/ja active Pending
- 2021-02-05 IL IL295291A patent/IL295291A/en unknown
- 2021-02-05 MX MX2022009709A patent/MX2022009709A/es unknown
- 2021-02-05 AU AU2021217919A patent/AU2021217919A1/en active Pending
- 2021-02-05 PH PH1/2022/552038A patent/PH12022552038A1/en unknown
- 2021-02-05 PE PE2022001547A patent/PE20221781A1/es unknown
- 2021-02-05 CR CR20220441A patent/CR20220441A/es unknown
- 2021-02-05 CN CN202180017750.8A patent/CN115380050A/zh active Pending
- 2021-02-05 BR BR112022015540A patent/BR112022015540A2/pt unknown
- 2021-02-05 WO PCT/SG2021/050061 patent/WO2021158178A1/en not_active Ceased
- 2021-02-05 KR KR1020227030781A patent/KR20220139930A/ko active Pending
- 2021-02-05 EP EP21751256.5A patent/EP4100443A4/en active Pending
- 2021-02-05 CA CA3170141A patent/CA3170141A1/en active Pending
-
2022
- 2022-07-28 JO JOP/2022/0175A patent/JOP20220175A1/ar unknown
- 2022-08-05 CL CL2022002114A patent/CL2022002114A1/es unknown
- 2022-08-05 DO DO2022000159A patent/DOP2022000159A/es unknown
- 2022-08-08 EC ECSENADI202261867A patent/ECSP22061867A/es unknown
- 2022-08-23 CO CONC2022/0011944A patent/CO2022011944A2/es unknown
-
2024
- 2024-07-09 CL CL2024002074A patent/CL2024002074A1/es unknown
- 2024-07-09 CL CL2024002073A patent/CL2024002073A1/es unknown
-
2025
- 2025-06-06 DO DO2025000135A patent/DOP2025000135A/es unknown
- 2025-10-14 JP JP2025172731A patent/JP2026027248A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108368170B (zh) | 抗pd-1抗体、可活化抗pd-1抗体及其使用方法 | |
| CN106659779B (zh) | 双特异性四价抗体及其制造和使用方法 | |
| JP2022532534A (ja) | ヒト免疫グロブリンヒンジ領域またはそのバリアントである２つの結合ドメイン間のリンカーを含む活性化可能な二重特異性抗体及びその使用 | |
| JP6875275B2 (ja) | Ｌ１ｃａｍ（ｃｄ１７）と結合する抗体などの結合分子 | |
| US20240392003A1 (en) | Multispecific antibodies having specificity for ror1 and cd3 | |
| WO2018089508A2 (en) | Anti-cd47 antibodies | |
| JP2020534830A5 (https=) | ||
| TWI815136B (zh) | 一種雙特異性抗體及其用途 | |
| CA3097193A1 (en) | Anti-dll3 antibodies and uses thereof | |
| JP2021530244A5 (https=) | ||
| JP2017536089A5 (https=) | ||
| TW202212355A (zh) | 多特異性抗體及其用途、用於產生其之方法、包括其之藥物組合物、編碼其之核酸序列、包括核酸序列的載體及包括載體的宿主細胞 | |
| KR20240049318A (ko) | Fap/cd40 결합 분자 및 이의 의학적 용도 | |
| TW202330605A (zh) | 靶向表現ｔｒｏｐ２之腫瘤細胞的結合劑 | |
| JP2025508317A5 (https=) | ||
| EP4110398A1 (en) | Antibodies conjugated with fatty acid molecules and uses thereof | |
| JP2025505650A5 (https=) | ||
| US20240019424A1 (en) | Method for resolving complex, multistep antibody interactions | |
| JP2025506341A5 (https=) | ||
| JP2023512827A5 (https=) | ||
| JP2022526555A (ja) | 多価分子の機能分析のための、ｓｐｒをベースとする結合アッセイ | |
| CN116249547B (zh) | 脑特异性血管生成抑制剂1(bai1)抗体及其用途 | |
| KR20240031229A (ko) | 알파-시누클레인병증 치료용 항체 | |
| CA3146977A1 (en) | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof | |
| TW202108631A (zh) | 一種抗ｃｄ４７抗原結合蛋白及其應用 |